|

sulforaphane Clinical Trials

2 actively recruiting trials across 1 location

Also known as: Avmacol Extra Strength

Pipeline

Phase 1/2: 2

Top Sponsors

  • Texas Tech University Health Sciences Center2

Indications

  • Heart Disease2
  • Diastolic Dysfunction1
  • Diastolic Heart Failure1
  • Systolic Dysfunction1
  • Anthracycline Related Cardiotoxicity in Breast Cancer1

Lubbock, Texas2 trials

Prevention of Age-associated Cardiac and Vascular Dysfunction Using Avmacol ES

Texas Tech University Health Sciences Center (TTUHSC)

Phase 1/2
Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction

Texas Tech University Health Sciences Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.